Published by Alexander Bueso on 14th September 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
URL: http://www.digitallook.com/dl/news/story/31173360/...